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ABSTRACT
OBJECTIVE
To determine the safety and efficacy of aerobic 
exercise on activities of daily living in the subacute 
phase after stroke.
DESIGN
Multicentre, randomised controlled, endpoint blinded 
trial.
SETTING
Seven inpatient rehabilitation sites in Germany  
(2013-17).
PARTICIPANTS
200 adults with subacute stroke (days 5-45 after 
stroke) with a median National Institutes of Health 
stroke scale (NIHSS, range 0-42 points, higher values 
indicating more severe strokes) score of 8 (interquartile 
range 5-12) were randomly assigned (1:1) to aerobic 
physical fitness training (n=105) or relaxation sessions 
(n=95, control group) in addition to standard care.
INTERVENTION
Participants received either aerobic, bodyweight 
supported, treadmill based physical fitness training 
or relaxation sessions, each for 25 minutes, five 
times weekly for four weeks, in addition to standard 
rehabilitation therapy. Investigators and endpoint 
assessors were masked to treatment assignment.
MAIN OUTCOME MEASURES
The primary outcomes were change in maximal 
walking speed (m/s) in the 10 m walking test and 
change in Barthel index scores (range 0-100 points, 
higher scores indicating less disability) three months 
after stroke compared with baseline. Safety outcomes 
were recurrent cardiovascular events, including 
stroke, hospital readmissions, and death within three 
months after stroke. Efficacy was tested with analysis 
of covariance for each primary outcome in the full 
analysis set. Multiple imputation was used to account 
for missing values.
RESULTS
Compared with relaxation, aerobic physical fitness 
training did not result in a significantly higher mean 
change in maximal walking speed (adjusted treatment 
effect 0.1 m/s (95% confidence interval 0.0 to 0.2 
m/s), P=0.23) or mean change in Barthel index score 
(0 (−5 to 5), P=0.99) at three months after stroke. A 
higher rate of serious adverse events was observed 
in the aerobic group compared with relaxation group 
(incidence rate ratio 1.81, 95% confidence interval 
0.97 to 3.36).
CONCLUSIONS
Among moderately to severely affected adults with 
subacute stroke, aerobic bodyweight supported, 
treadmill based physical fitness training was not 
superior to relaxation sessions for maximal walking 
speed and Barthel index score but did suggest 
higher rates of adverse events. These results do not 
appear to support the use of aerobic bodyweight 
supported fitness training in people with subacute 
stroke to improve activities of daily living or 





Despite encouraging advances in the early treatment 
of stroke,1 at least one third of the 10 million people 
worldwide with new stroke each year2 remain 
functionally dependent and as a result experience 
impairments in activities of daily living.3 4 The number 
of stroke survivors with impairments in activities 
of daily living is increasing, leading to more people 
with stroke who are dependent on rehabilitation 
interventions.5 To date, no drug treatments are 
available to enhance rehabilitation. Treadmill based 
physical fitness training constitutes a non-drug 
approach in stroke rehabilitation that might not only 
prevent deconditioning but also show associated 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Current guidelines endorse cardiorespiratory training within post-stroke 
rehabilitation programmes
Large randomised controlled trials of this recommendation are scarce, resulting 
in inconclusive data on efficacy for disability (activities of daily living) and safety 
of physical fitness training after stroke
WHAT THIS STUDY ADDS
Results suggest that in adults with moderate to severe subacute stroke, in 
addition to standard rehabilitation care, aerobic, bodyweight supported, 
treadmill based fitness training did not improve maximal walking speed or 
activities of daily living compared with relaxation
The rate of serious adverse events was higher in the aerobic physical fitness 
training group than relaxation group
Compared with current guideline recommendations, these results do not appear 
to support the use of aerobic, bodyweight supported, treadmill based fitness 
training in this stroke population
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benefits on activities of daily living, such as walking 
and climbing stairs.6-8
A meta-analysis of small randomised controlled 
trials showed improvements in speed and tolerance 
of walking after physical fitness training in stroke 
survivors.6 The studies have, however, varied in type 
and intensity of exercise, timing of initiation after 
stroke, and control groups.7 9-11 The American Heart 
Association/American Stroke Association currently 
recommends aerobic exercise for stroke survivors, with 
three to five sessions weekly lasting 20 to 60 minutes 
and at a heart rate of 55-80% of the maximum. Applied 
in the subacute stage after stroke, aerobic exercise 
is thought to promote neuroplasticity and to have 
beneficial effects on functional outcomes.7 So far, nine 
randomised controlled trials (n=324) have compared 
the effects of aerobic physical fitness training on 
maximal walking speed—an important indicator of 
mobility in everyday life6—with a control intervention. 
However, only two of these studies (n=73) enrolled 
participants within the first six weeks after stroke, and 
these participants showed improvement in maximal 
walking speed post-intervention.6 For activities of 
daily living and disability, two small randomised 
rehabilitation trials (n=199) that applied 400-540 
minutes of physical fitness training in the early and 
late subacute stage after stroke found an increase in 
the Barthel index score, a disability scale widely used 
in the clinical setting to measure activities of daily 
living.12 13 Meta-analyses have, however, indicated that 
the evidence for improvement in Barthel index scores 
after physical fitness training is still inconclusive.6
Previously, the larger Locomotor Experience Applied 
Post-Stroke (LEAPS) trial randomised 408 participants 
to treadmill based locomotor training either two or 
six months after stroke, or to a progressive exercise 
programme at home, and did not detect a difference in 
treatment effects.11 LEAPS did not, however, apply an 
aerobic physical fitness training early after stroke.
We performed a multicentre, randomised controlled 
trial in adults with stroke in the early subacute phase 
(days 5-45 after stroke) to determine the efficacy of 
aerobic treadmill based, physical fitness training on 
maximal walking speed and activities of daily living 
compared with relaxation as a control intervention.
Methods
Study design
The study protocol for the multicentre, randomised 
controlled, endpoint blinded Physical Fitness Training 
in Patients with Subacute Stroke (PHYS-STROKE) trial 
is available online (https://doi.org/10.1186/1745-
6215-15-45) and has been published previously.14 
All participants provided informed consent. Adults 
were enrolled at seven inpatient rehabilitation sites 
in Berlin, Germany, and the surrounding area. A 
medical monitoring and independent data safety 
and monitoring board was appointed by the Centre 
for Stroke Research Berlin. Guidance of study centre 
representatives was maintained by regular telephone 
contact and study visits by members of the coordinating 
trial centre at the Centre for Stroke Research Berlin. To 
determine eligibility for the trial, trained trial physicians 
screened people with an imaging confirmed diagnosis 
of ischaemic or haemorrhagic stroke who had been 
admitted to hospital within a recruiting centre.
Participants
People were eligible for the trial if they were aged at 
least 18 years, were in the subacute phase of ischaemic 
or haemorrhagic stroke (days 5-45 after stroke onset), 
were able to sit unsupported for at least 30 seconds, 
were considered able to perform aerobic exercise by 
the responsible trial physician, and had a Barthel 
index score of 65 or less at the time of enrolment. The 
Barthel index measures activities of daily living based 
on 10 items, with scores ranging from 0 to 100 points—
higher scores indicating less dependence.15 Key 
exclusion criteria were intracranial haemorrhage from 
a ruptured aneurysm or arteriovenous malformation, 
inability to perform required physical exercise, assisted 
walking before stroke, or severe cardiac or psychiatric 
comorbidities. If study requirements were met, trial 
physicians assessed information on stroke type and 
medical conditions after written informed consent was 
obtained. The supplementary file lists the inclusion 
and exclusion criteria.
Randomisation and blinding
Participants were stratified by age (≤65 years, >65 
years), functional ambulation category (scores ≤3, 
>3), and centre and were randomised using a web 
based tool in a 1:1 ratio to receive aerobic physical 
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fitness training or relaxation sessions (control 
group) in addition to standard care.16 The functional 
ambulation category is a six point scale that assesses 
dependency on walking aids, with higher scores 
indicating less dependency. Trained study assessors 
(physiotherapists, occupational therapists) collected 
information on participant characteristics and clinical 
data from chart reviews at baseline visits and carried 
out outcome assessments at baseline and follow-up. 
Study assessors and the trial statistician were blinded 
to the intervention allocation.
Interventions
Therapists at each rehabilitation site performed 
interventions according to standardised protocols 
taught by a manual and two day training course. The 
study interventions were applied during inpatient stay 
at the rehabilitation centre, in addition to standard 
rehabilitation therapy according to German guide-
lines (www.bar-frankfurt.de). The supplementary 
file provides detailed information on the amount and 
content of standard care. Each study session was for 
50 minutes (therapist led), comprising 25 minutes of 
core intervention (training aimed at target heart rate or 
relaxation time), and took place five times weekly over 
four weeks (20 sessions in total). The start and end of 
each intervention session as well as the duration of the 
core intervention were documented for each participant. 
An intervention period of four weeks was chosen to 
ensure intervention sessions were applied during 
the length of the inpatient stay at the rehabilitation 
centres. This also enabled the assessment of short term 
outcomes at three months after stroke.
The supplementary appendix provides a detailed 
description of the aerobic physical fitness training and 
relaxation interventions. Briefly, the aerobic physical 
fitness training sessions included treadmill based, 
bodyweight supported training at a cardiorespiratory 
active (aerobic) level to reach a target heart rate for 25 
minutes. The target heart rate was calculated by the 
formula 180 minus years of age, a pragmatic decision, 
which resembles conventional approaches for 
calculation of target heart rate that is 50-60% of each 
participant’s maximum heart rate (see supplementary 
appendix). If participants used β blockers, we 
reduced the target heart rate by 10 beats per minute. 
Participants used a bodyweight supported treadmill 
(Multi-disk treadmill Callis, Model Therapie; Sprintex 
Trainingsgeräte, Kleines Wiesental, Germany; Reha-
Stim, Berlin, Germany) if their functional ambulation 
category score was 3-5 or an electromechanical gait 
trainer (Gait Trainer GT1; Reha-Stim, Berlin, Germany) 
if their score was 0-2. The amount of bodyweight 
support was applied as required. If necessary, one 
or two therapists assisted with leg movement, such 
as extending hip and knee, shifting body weight, or 
setting the paretic leg in the case of severe paresis of 
the peroneus muscles. Participants used the same 
orthoses during the intervention as during standard 
care physiotherapy. Each training session, including 
preparation time and a warm-up and cool-down 
phase, lasted 50 minutes and comprised 25 minutes 
of active training at aimed target heart rate, depending 
on each participant’s ability, as recommended in 
current guidelines.7 To ensure target heart rate was 
maintained, heart rate during training was controlled 
through a pulse sensor (Polar FT1 HRM, Polar Electro 
Oy, Kempele, Finland) and a screen attached to the 
treadmill or gait trainer. Reduction of bodyweight 
support and an increase of belt speed or increase of 
inclination, or both was used to reach the target heart 
rate throughout the four week intervention, and thus to 
constantly induce aerobic training effects. The trainers 
documented changes of these variables during the 
intervention period and individual perceived exertion 
after each training session in intervention diaries. 
To prevent falls, participants were equipped with a 
modified parachute harness (Belt system; Reha-Stim, 
Berlin, Germany).
Relaxation sessions were performed as an active 
control and focused on contraction and relaxation of 
muscle groups in the face, arms, shoulders, back, and 
abdomen for 25 minutes. Participants were instructed 
to contract the muscles for five to 10 seconds then to 
relax for 30-40 seconds and were encouraged to pay 
attention to the feelings of warmth and heaviness. 
Sessions aimed to promote mental and physical 
relaxation and avoid any cardiovascular stress. 
Participants’ heart rates were monitored during the 
relaxation sessions, and ratings of perceived exertion 
were assessed at the end of each session. Participants 
in both groups received individual attention during 
each session to achieve comparability.
No specific treatment policy was prescribed after 
the intervention period. If participants stopped the 
intervention prematurely, we continued clinical 
follow-up at set time points. Participants were 
analysed in the per protocol analysis if they received 
75% or more of the scheduled intervention sessions, 
had not suspended the intervention for more than five 
consecutive days, and had participated in the follow-
up visit three months after stroke.
Outcome measures
Study visits for outcome assessment were performed 
before and after the intervention period as well as three 
and six months after stroke. The primary outcome 
measures were change in maximal walking speed 
(assessed in m/s) and change in Barthel index scores 
three months after stroke compared with baseline 
in the intention-to-treat analysis. Maximal walking 
speed was assessed in a 10 m walk test.17 Participants 
were asked to walk at maximal speed for 14 m—2 
m for acceleration and 2 m for deceleration, with 
markings on the floor for starting point, at 2 m (start 
of measurement) and 12 m (end of measurement). 
The time taken for the walk was measured manually 
using an electronic time watch for all participants 
and was additionally controlled with a light beam to 
trigger an additional watch (Wilhelm Köster Ingenieur 
für Zeitmessung, Ditzingen, Germany). The test was 
performed twice and mean speed calculated to avoid 
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test-retest error. Prespecified secondary outcomes 
included the six minute walk test (in metres), 
Rivermead mobility index18 (range 0-15, with higher 
scores indicating better mobility), actigraphy for 24 
hours (in steps daily, assessed with GT3x; Actigraph, 
Pensacola, FL), modified Rankin scale (mRS) score (a 
scale assessing disability after stroke; ranging from 0 
for no symptoms to 6 for death), as well as measures of 
cognition, motor function, spasticity, mood, and sleep 
at follow-up compared with baseline. Additionally, in a 
per protocol dataset we analysed changes in maximal 
walking speed and Barthel index score three months 
after stroke compared with baseline. Prespecified 
biomarker and imaging outcome measures will be 
analysed separately within an accompanying study,19 
as described in the statistical analysis plan. The 
supplementary appendix describes the assessments 
of secondary outcomes. Main prespecified subgroup 
analyses included dichotomisation of impairment 
scores (National Institutes of Health stroke scale 
(NIHSS)20 assessed on days 3-5 after stroke, a scale 
that measures neurological deficits, ranging from 0 to 
42 points, with higher values indicating more severe 
strokes, and functional ambulation category), type 
of stroke, time of study inclusion, and age and sex 
of participants. We carried out additional post hoc 
exploratory analyses of differential treatment effects 
for continuous variables using splines.21
Primary safety outcomes included the serious adverse 
events of recurrent cardiovascular events, including 
stroke, admission to an acute care hospital, or death 
within three months after stroke. Trial physicians 
reported these outcomes to the coordinating trial centre 
within 24 hours. The adverse events of self reported 
pain, fatigue, dizziness, and number and nature of falls 
during the intervention period were recorded after each 
intervention session. We reported adverse events to the 
data safety monitoring board on a regular basis.
Statistical analysis
To show the superiority of the aerobic physical fitness 
training over relaxation intervention, the study was 
powered on the primary outcome measures to detect 
a clinically meaningful difference of 0.13 m/s in maxi-
mal walking speed (common standard deviation of 
0.25 m/s) or 10 points in Barthel index score (common 
standard deviation of 21 points).14 Assumptions were 
based on reported clinical differences from a previous 
study of another working group (n=155).13 Overall, 
172 participants (86 in each group) were needed to 
provide 80% power to detect a statistically significant 
treatment effect for each of the primary endpoints 
(maximal walking speed and Barthel index score 
at three months compared with baseline; two sided 
significance level α=0.025 for each primary outcome, 
two sample t test). Accounting for a 20% dropout rate, 
we planned a total sample size of 215 participants. The 
predefined analyses have been performed as described 
in the statistical analyses plan of the trial (version 1.0, 
available online) and were conducted using SPSS, 
STATA, and R statistical software.22-24
All randomised participants were included in the 
full dataset for the intention-to-treat analysis. Group 
differences for each primary outcome were analysed 
using two separate analyses of covariance, with 
baseline measures as covariates and an additional 
random effect (random intercept model) to account 
for clustering of participants in centres. The primary 
outcomes at follow-up (maximal walking speed and 
Barthel index score three months after stroke) were the 
dependent variables in these analyses, and baseline 
scores and intervention group were independent 
variables. Additionally, we adjusted the analyses for 
age, sex, and functional impairment (as assessed by 
the functional ambulation category test). We imputed 
missing data because of attrition by using multivariate 
imputation by chained equations (mice) based on 10 
imputed datasets and relevant information generated 
by the R package mice.25 The supplementary appendix 
provides detailed descriptions of data imputation and 
handling missing data. If we were unable to assess data 
on mobility measures at baseline because of severe 
impairment, reasonable single value imputation was 
carried out by using half the speed of the slowest 
participant in the group. Analyses of safety endpoints 
were done using Poisson regression models, which 
account for the time each participant is at risk and 
allows incidence rate and incidence rate ratios with 
confidence intervals to be calculated.
Prespecified subgroup analyses for the primary 
outcomes were exploratory for sex, age groups, type of 
stroke, impairment measured by NIHSS and functional 
ambulation category, and time from stroke to start of 
intervention. For each subgroup analysis, we tested 
the interaction between treatment allocation and 
subgroup to test whether any difference in treatment 
effect between subgroups was substantial. For each 
subgroup we also provided mean treatment effects and 
95% confidence intervals.
Secondary outcome measures were analysed 
using a three level mixed model where the repeated 
measures were nested in participants and participants 
were nested in centres. We used baseline variables 
of outcomes as covariates. Models were additio-
nally adjusted for age, sex, and baseline functional 
ambulation category. In all models we included 
interaction terms for time point and treatment group. 
Reported effect estimates were calculated using post-
estimation procedures. All models (except for mRS 
and functional ambulation category) are based on 10 
imputations with chained equations and groupwise 
imputation (see supplementary table S3). For the mRS 
and functional ambulation category, we used an ordinal 
logistic mixed regression model including respective 
covariates for adjustment and random intercept to 
account for repeated measures. The group variable 
for centre was entered as fixed covariate in the ordinal 
mixed models to avoid instability of models. Variables 
with non-normal distribution were log transformed 
before analyses. All secondary analyses were carried 
out in an exploratory framework. No adjustment for 
multiple testing was applied for secondary analyses.
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Patient and public involvement
Before and during the trial, a patient representative 
appointed by the Berlin Stroke Alliance participated in 
meetings of the trial’s executive steering committee. A 
member of the trial centre informed the Berlin Stroke 
Alliance (including participants and family members) 
about the progress of the trial on a regular basis. After 
the last trial visit, each participant received a summary 
of his or her personal outcome measures and blood 
test results. Findings of the trial will be shared with all 
participants by providing access to the full manuscript. 
The supplementary appendix provides a section for 
participants and carers who provided additional 
information.
Results
From 26 September 2013 to 30 April 2017, a total 
of 12 866 adults were screened of whom 200 were 
included in the trial and underwent randomisation 
(105 were assigned to aerobic physical fitness training 
Start of intervention
Adults with stroke admitted to rehabilitation sites
Ineligible
Not seen by recruiter
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Fig 1 | Flowchart of enrolment and randomisation. Multiple imputation was performed for intention-to-treat analyses 
of full analysis dataset
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and 95 to relaxation sessions (control group) in 
addition to standard care (fig 1). The main reasons 
for exclusion were a Barthel index score greater than 
65, stroke onset more than 45 days before screening, 
and presence of comorbidities at the time of screening 
(mainly cardiac). The full analysis set entered the 
intention-to-treat analysis. The mean age of the study 
cohort was 69 (SD 12) years and 41% were women. 
The median NIHSS score was 8 (interquartile range 
5-12) points at days 3-5 after stroke. Baseline personal 
and clinical characteristics were similar in both 
study groups, except for the six minute walk test 
and Rivermead mobility index, which were higher 
in the relaxation group. Table 1 lists the baseline 
characteristics. The amount of physiotherapy applied 
during inpatient and outpatient standard care between 
baseline and follow-up visit three months after stroke 
was similar between groups (see supplementary table 
S14).
The median time from stroke onset to start of 
intervention was 28 (interquartile range 17-40) days. 
Adherence to the study protocol was good to moderate 
(fig 2). The mean delta heart rate (pre-post intervention) 
was 15 (SD 9) beats per minute (bpm) in participants 
assigned to aerobic physical fitness training compared 
with −2 (SD 3) bpm in participants assigned to 
relaxation. Among participants randomised to aerobic 
physical fitness training, the median percentage of 
training sessions performed at target heart rate was 70% 
(interquartile range 23-100%) with improved adherence 
towards the end of the intervention period (fig 2). The 
amount of therapy applied during standard care was 
similar for severely impaired participants (functional 
ambulation category 0-1) compared with less severely 
impaired participants (>1), indicating similar treatment 
conditions (see supplementary table S7). Participants 
in the aerobic physical fitness training group received a 
mean of 16 (SD 6) sessions with a mean duration of the 
core intervention of 21 (SD 4) minutes, compared with a 
mean 17 (SD 5) sessions and mean duration of 24 (SD 3) 
minutes in the relaxation group. Eighteen participants 
in the aerobic physical fitness training group (17%) 
did not reach the required amount of 15 intervention 
sessions, compared with 11 participants (12%) in the 
relaxation group. Main reasons for termination of the 
intervention were early transfer to a non-participating 
hospital (n=4, each group) and a serious adverse event 
(n=5 in aerobic physical fitness training group; n=3 in 
relaxation group, see fig 1). At three months after stroke, 
34 participants (17%) were lost to follow-up, and 
respective data were imputed for the intention-to-treat 
analysis using multiple imputation methods (see 
supplementary appendix for detailed description). 
The prespecified per protocol analysis comprised data 
for 151 participants (76% of the full analysis set), 80 
participants in the aerobic physical fitness training 
group and 71 in the relaxation group.
Table 2 lists the primary efficacy outcomes. The 
adjusted mean change of maximal walking speed 
from baseline to three months after stroke was 0.4 
m/s (95% confidence interval 0.3 to 0.4 m/s) in the 
aerobic physical fitness training group and 0.3 m/s 
(0.2 to 0.4  m/s) in the relaxation group, resulting in 
an adjusted treatment effect of 0.1 m/s (0.0 to 0.2 m/s; 
P=0.23, primary efficacy outcome). The adjusted mean 
change in Barthel index score three months after stroke 
was 30 points (95% confidence interval 24 to 36) in the 
aerobic physical fitness training group compared with 
30 points (23 to 36) in the relaxation group, resulting 
in an adjusted treatment effect of 0 (95% confidence 
interval −5 to 5; P=0.99, primary efficacy outcome). 
Figure 3 shows the change in maximal walking speed 
and Barthel index score during the trial.
In the per protocol analysis, the mean change in 
maximal walking speed was 0.4 m/s (95% confidence 
interval 0.3 to 0.5 m/s) in the aerobic physical fitness 
training group and 0.3 m/s (0.2 to 0.4 m/s) in the 
relaxation group, resulting in a treatment effect of 
0.1 m/s (95% confidence interval −0.1 to 0.2 m/s). 
The mean increase in Barthel index score after three 
months was similar in both groups: aerobic physical 
fitness training 32 (95% confidence interval 28 to 
37) versus relaxation 31 (27 to 35); treatment effect 
1 (95% confidence interval −4 to 6). Figure 4 shows 
the results for the prespecified subgroup analyses. 
Exploratory subgroup analysis for maximal walking 
speed suggested a greater treatment effect in women 
than in men: 0.3 (95% confidence interval 0.1 to 0.5) v 
0.0 ( −0.2 to 0.1); P=0.01 for interaction. Figure 5 and 
supplementary figure S2 show the results for subgroup 
analyses of continuous variables using splines.
All secondary analyses were done in an exploratory 
framework. Overall, no substantial differences in 
maximal walking speed or Barthel index score between 
groups were observed at the end of intervention or at 
follow-up six months after stroke (table 3).
Table 1 | Baseline characteristics of participants stratified by aerobic physical fitness 
training or relaxation sessions (control group). Values are numbers (percentages) unless 
stated otherwise
Characteristic






Mean (SD) age (years) 69 (12) 70 (11) 69 (12)
Women 45 (43) 36 (38) 81 (41)
Median (interquartile range) time from 
stroke to intervention (days)*
30 (17-39) 27 (17-41) 28 (17-40)
Anterior circulation stroke 84 (80) 72 (76) 156 (78)
Hemiparesis on admission 98 (93) 89 (94) 188 (94)
Median (interquartile range) NIHSS 
score†
9 (5-12) 7 (5-11) 8 (5-12)
Ischaemic stroke 91 (87) 90 (95) 181 (91)
Treatment with alteplase‡ 34 (37) 27 (30) 61 (34)
Cause of ischaemic stroke‡:
 Large artery atherosclerosis 17 (19) 19 (21) 36 (20)
 Cardioembolism 18 (20) 18 (20) 36 (20)
 Small vessel occlusion 16 (18) 15 (17) 31 (17)
 Other causes 3 (3) 4 (4) 7 (4)
 Undetermined causes 34 (37) 28 (31) 62 (34)
 Competing causes 3 (3) 6 (7) 9 (5)
Previous stroke 27 (27) 27 (28) 54 (27)
NIHSS=National Institutes of Health stroke scale.
*Four participants were excluded at screening.
†Scores range from 0 to 42, with higher scores indicating greater stroke severity. Assessed on days 3-5 after 
stroke. Hospital chart was missing for one participant.
‡Reported proportions of participants treated with alteplase and proportions of causes of stroke refer only to 
participants with ischaemic stroke. Protected by copyright.  o
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The six minute walk test showed a mean adjusted 
difference of 27 m (95% confidence interval 0 to 54 m) 
in favour of aerobic physical fitness training compared 
with relaxation at three months after stroke (adjusted for 
baseline, age, sex, and functional ambulation category). 
Other exploratory secondary analyses did not show 
substantial differences between study groups three 
months after stroke. At follow-up six months after stroke, 
the relaxation group showed greater improvements in 
the resistance to passive movement scale sum score 
(treatment effect 2.6 (95% confidence interval 0.6 to 
4.5)) and the Rivermead mobility index subtest arm 
(treatment effect −1.1 (−2.0 to 0.0)) compared with 
aerobic physical fitness training (table 3).
The aerobic physical fitness training group had a 
higher rate of serious adverse events (n=22) than the 
relaxation group (n=9) at three months after stroke 
(incidence rate ratio 1.81, 95% confidence interval 
0.97 to 3.36). Fourteen participants in the aerobic 
physical fitness training group were admitted to acute 
hospitals compared with five in the relaxation group 
(2.53, 0.91 to 7.04). Recurrent strokes occurred in eight 
participants in the aerobic physical fitness training 



































































































































































































Light bodyweight support (1-9%)
Intermediate bodyweight support (10-15%)




Heavy bodyweight support (>15%)
Fig 2 | Progression of training modalities during intervention period. (A) Distance (m) achieved (only available for participants who used treadmill). 
(B) Walking speed (km/h) reached on treadmill. (C) Change in incline (%) on treadmill (only available for participants who used treadmill). (D) 
Proportion of participants with different levels of bodyweight support over time. (E) Mean change in heart rate by group measured before and after 
intervention sessions during intervention period. (F) Proportion of participants who achieved their target heart rate during training. Participants are 
grouped by baseline functional ambulation category (FAC) score of 0-2 and 3-5 (higher scores indicate less dependency)
Table 2 | Results for primary efficacy outcome of change in maximal walking speed 
and Barthel index score from baseline to three months after stroke by aerobic physical 
fitness training or relaxation sessions (control group)




treatment effect* P value
Mean (95% CI) maximal 
walking speed (m/s) 0.4 (0.3 to 0.4) 0.3 (0.2 to 0.4) 0.1 (0.0 to 0.2) 0.23
Mean (95% CI) Barthel 
index score 30 (24 to 36) 30 (23 to 36) 0 (−5 to 5) 0.99
Analyses based on multiple imputation.
*Treatment effects were analysed using analysis of covariance mixed models with three month outcome 
as dependent variable adjusted for baseline and additionally adjusted for sex, study centre, and functional 
ambulation category.
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(2.41, 0.64 to 9.10). No serious adverse events occurred 
during intervention sessions. Self reported falls during 
the intervention period occurred more often in the 
aerobic physical fitness training group (2.34, 1.26 to 
4.34) and self reported dizziness occurred more often 
in the relaxation group (0.33, 0.12 to 0.90, table 4).
Discussion
In adults with moderate to severe subacute stroke 
receiving standard inpatient rehabilitation therapy, 
a four week intervention of additional aerobic 
physical fitness training was not superior to a control 
intervention based on relaxation in improving 
activities of daily living and maximal walking speed 
three months after stroke. Analysis of safety showed an 
increased risk of falls during the treatment period and 
suggested a higher number of acute hospital admissions 
and recurrent strokes in participants randomised to 
aerobic physical fitness training. For clinical practice, 
the results of this pragmatic trial26 do not support the 
use of aerobic physical fitness training in moderately or 
severely affected adults in the subacute phase of stroke.
Comparison with other studies
The treatment effects in mobility outcomes observed in 
the current study are in line with results reported in the 
latest Cochrane Collaboration meta-analysis of physical 
fitness trials after stroke6 and randomised trials of 
circuit class training interventions.27 28 In our trial, 
however, neither the intention-to-treat analysis nor the 
per protocol analysis showed a substantial difference 
in maximal walking speed between study groups. This 
finding contrasts with that of previously published 
trials reporting beneficial effects of fitness training on 
maximal walking speed.29-31 Interventions in these 
previous trials were compared with usual care only, 
however, and the reported improvements were in smaller 
cohorts comprising participants with late subacute or 
chronic stroke and less severe disability. As recently 
endorsed by the Stroke Recovery and Rehabilitation 
Roundtable taskforce, trials should focus on the early 
subacute phase of stroke (days 7-90 after stroke)10; in 
the present trial more than 99% of participants were 
recruited in this subacute phase. This phase is thought 
to be a critical time for neuroplasticity32 and therefore 
might serve as an important period for rehabilitation 
to harness endogenous neural repair. Despite early 
enrolment of participants to our trial, we were not able 
to show enhanced treatment effects. Interestingly, a 
recent meta-analysis of randomised controlled trials on 
bodyweight supported treadmill training after stroke 
concluded that participants who walked independently 
(functional ambulation category score >2) improved in 
walking speed and walking endurance, whereas those 
who were not able to walk independently (score 0-2) 
did not improve with treadmill training.33 This fact 
could explain why our trial failed to show a statistically 
significant improvement in primary outcome 
measures, given that about 75% of the study cohort 
had functional ambulation category scores between 
0 and 2 at baseline. However, no interaction between 
functional ambulation category score and treatment 
effect was observed in the respective subgroup analysis 
(fig 4 and supplementary figure S2). No treatment 
effect was observed with activities of daily living three 
months after stroke, which contrasts with the findings 
of smaller, previous trials including participants in 
the early and late subacute stage of stroke.12 13 Until 
now, evidence that physical fitness reduces disability 
after stroke has been inconclusive for activities of 
daily living, and positive effects on disability after 
stroke could primarily derive from improvements in 
mobility.6 Aerobic physical fitness training compared 
with relaxation had no beneficial effect on scores on 
the Barthel index, functional ambulation category, or 
modified Rankin scale (see tables 2 and 3). Current 
outcome measures of activities of daily living differ in 
sensitivity, and the Barthel index might not be sensitive 
enough to capture small but clinically meaningful 
differences in activities of daily living related to aerobic 
training after stroke. Exploratory analyses of secondary 
outcome measures suggested small beneficial effects 
in fitness measures for participants randomised to 
aerobic physical fitness training at three months after 
stroke, as reflected in the six minute walk test (see table 
3). This was a secondary exploratory finding, however, 
and cannot be used for inferences on treatment effects. 
Treatment arm













































Fig 3 | Boxplot showing medians (interquartile ranges) for maximal walking speed 
assessed by 10 m walk test (top panel), and Barthel index score (bottom panel) for each 
study visit and intervention group. Data are based on measurements without multiple 
imputation. Number of participants at each scheduled study visit was: baseline (n=105 
in aerobic physical fitness training group, n=95 in relaxation group:), post-intervention 
(n=87, n=85), three months post-stroke (n=89, n=77), and six months post-stroke 
(n=80, n=65). Dots represent outliers
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0.3 (0.1 to 0.5)
0.3 (0.2 to 0.4)
30 (23 to 36)
31 (25 to 37)
29 (22 to 36)
30 (22 to 37)
30 (22 to 37)
31 (23 to 38)
31 (25 to 36)
24 (8 to 39)
31 (25 to 37)
29 (21 to 36)
28 (22 to 35)
34 (26 to 42)
31 (22 to 39)
30 (24 to 37)
Relaxation
0.4 (0.3 to 0.4)
0.3 (0.2 to 0.4)
0.5 (0.3 to 0.6)
0.5 (0.4 to 0.7)
0.2 (0.1 to 0.4)
0.3 (0.1 to 0.4)
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0.4 (0.2 to 0.6)
0.4 (0.2 to 0.5)
0.3 (0.2 to 0.5)
0.4 (0.3 to 0.5)
0.3 (0.1 to 0.5)
0.4 (0.2 to 0.6)
0.3 (0.2 to 0.5)
30 (24 to 36)
30 (24 to 36)
30 (23 to 36)
36 (29 to 43)
27 (20 to 35)
27 (19 to 34)
30 (25 to 36)
28 (18 to 38)
31 (25 to 38)
28 (21 to 35)
28 (22 to 34)
37 (28 to 46)
29 (20 to 38)



















Mean changes (95% CI)
-15 0 20
Fig 4 | Prespecified subgroup analyses. Forest plots display maximal walking speed and Barthel index scores. Results 
are based on multiple imputation. No data were available for time from stroke to intervention for four participants who 
were excluded at screening. National Institutes of Health Stroke scale (NIHSS) score was missing for one participant 
owing to missing hospital chart. FAC=functional ambulation category. *P value for primary outcome measure. †P 
values for age×group interaction
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Thus, adequately powered trials need to confirm 
whether bodyweight supported, treadmill based, 
aerobic physical fitness training improves measures of 
endurance at a clinically important level in this stroke 
population.
No safety concerns were reported for aerobic 
physical fitness training in the early subacute phase 
in two smaller previous studies comprising survivors 
of mild to moderate stroke.34 35 However, in the large 
randomised controlled LEAPS trial, the proportion of 
participants with multiple falls was higher in the early 
locomotor training group (starting two months after 
stroke) compared with the late locomotor training 
group (starting six months after stroke).11 Similarly, 
in the current trial, falls occurred more often in the 
aerobic physical fitness training group than in the 
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Fig 5 | Subgroup analyses of continuous variables using splines. Differences in maximal walking speed and Barthel index scores (follow-up three 
months after stroke-baseline) as a function of age and National Institutes of Health stroke scale (NIHSS) score at days 3-5 after stroke
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ing (n=105), relaxation 
sessions (n=95)
Post-intervention: 
aerobic physical fitness 
training (n=87), relaxa-
tion sessions (n=85)
Follow-up Treatment effect (95%CI)*
3 months: aerobic 
physical fitness train-
ing (n=89), relaxation 
sessions (n=77)
6 months: aerobic 
physical fitness train-








Median (interquartile range); mean (SD) maximal walking speed (m/s)†





(−0.04 to 0.22)Relaxation 0.3 (0.1-0.7); 0.5 (0.4) 0.6 (0.3-0.8); 0.6 (0.6) 0.6 (0.4-0.9); 0.8 (0.7) 0.8 (0.4-1.3); 0.9 (0.9)
Median (interquartile range); mean (SD) Barthel index score
Aerobic training 50 (35-60); 47 (16) 75 (60-90) 73 (21) 80 (61-100); 77 (22) 90 (70-100); 82 (20) 0 (−4 to 5) Primary outcome
−1  
(−6 to 3)Relaxation 55 (35-65); 49 (17) 80 (60-90); 75 (22) 80 (70-95); 79 (19) 90 (70-100); 84 (18)
Median (interquartile range); mean (SD) 6 minute walk distance (m)‡
Aerobic training 75 (32-160); 107 (110) 145 (85-245);  
175 (126) (n=81)
165 (90-300);  
201 (153) (n=85)
220 (110-350); 239 
(152) (n=77) 19 (−8 to 46) 27 (0 to 54) 26  (−1 to 53)Relaxation 120 (39-205); 139 
(113)
179 (91-244);  
185 (115) (n=78)
180 (110-263);  
203 (128) (n=71)
208; (114-323) 233 
(149) (n=64)
Mean (SD) Rivermead mobility index score
Aerobic training 5 (3) 8 (4) 9 (4) 11 (4) 0.2  
(−0.6 to 1.0)
0.3 (−0.5 to 
1.1) 0.0 (−0.8 to 0.8)Relaxation 6 (3) 9 (4) 9 (4) 11 (4) (n=65)
Median (interquartile range) modified Ranking scale score
Aerobic training 4 (4-4) 4 (3-4) 3 (2-4) (n=90) 3 (2-4) 2.0 (0.6 to 6.9)§ 0.8 (0.2 to 2.5)§ 1.1 (0.3 to 3.6)§Relaxation 4 (3-4) 3 (3-4) 3 (3-4) (n=78) 3 (2-4)
Median (interquartile range) actigraphy (steps/day)¶
Aerobic training 3263 (1815-5515); 
(n=97)










−566 (−1497 to 
365)Relaxation 3503 (1949-6328); 
(n=88)






Median (interquartile range) step length (m)**
Aerobic training 0.31 (0.23-0.44); 
(n=99)









0.03 (−0.01 to 
0.07)Relaxation 0.39 (0.29-0.48); 
(n=93)






No (%) used walking aid




0.30§ (0.06 to 
1.57)Relaxation 60 (78) (n=77) 59 (76) (n=78) 52 (72) (n=72) 42 (68) (n=62)
Median (interquartile range) step cadence (steps/min)††
Aerobic training 53 (29-91); (n=99) 68 (46-102);  (n=84)
91 (54-116);  
(n=88)
100 (59-128);  
(n=78) 2 (−7 to 12) 6 (−4 to 15) 3 (−7 to 12)Relaxation 70 (36-92); (n=93) 80 (57-99);  (n=83)
90 (65-113);  
(n=76)
98 (68-126);  
(n=64)
Median (interquartile range) box and block test, impaired hand/non-impaired hand‡‡
Aerobic training 0 (0-31) / 46 (34-54) 
(n=100)
12 (0-38) /  
48 (40-58) /
19 (0-39) /  
53 (40-62)
27 (0-44) /  
54 (42-62) 1 (−3 to 6) 1 (−3 to 5) −1 (−6 to 3)Relaxation 2 (0-23) / 45 (35-52) 
(n=89)
12 (0-34) /  
46 (39-56) /
23 (0-35) /  
45 (38-56)
28 (3-43) /  
50 (39-60)
Mean (SD) Rivermead mobility index score: subtest arm
Aerobic training 5 (5) 6 (6) 6 (6) 8 (6) −0.7 (−1.6 to 
0.2)
−0.9 (−1.8 to 
0.0)
−1.1 (−2.0 to 
0.0)Relaxation 5 (5) 7 (5) 8 (5) 9 (5)
Mean (SD) medical research council scale, sum score over six items§§
Aerobic training 19 (8) (n=104) 22 (7) (n=86) 22 (6) 23 (7) 0.3 (−0.8 to 1.4) −0.3 (−1.4 to 0.8)
−0.2 (−1.3 to 
0.9)Relaxation 20 (8) 22 (7) (n=85) 23 (7) 24 (5)
Mean (SD) resistance to passive movement scale sum score
Aerobic training 4 (5) 6 (6) 8 (9) (n=88) 11 (14) 0.9 (−1.0 to 2.9) 1.6 (−0.3 to 3.6) 2.6 (0.6 to 4.5)Relaxation 4 (5) 5 (6) 6 (7) (n=77) 9 (9)
Median (interquartile range ) functional ambulation category score¶¶
Aerobic training 2 (1-2) 3 (2-3) (n=56) 3 (2-4) (n=52) 4 (2-5) (n=47) 0.3 (0.1 to 1.6)§ 0.9 (0.2 to 5.0)§ 1.1 (0.2 to 6.2)§Relaxation 2 (1-3) 3 (2-4) (n=57) 3 (2-4) (n=44) 3 (3-4) (n=33)
Median (interquartile range) gait energy cost (ml/kg-1/m-1)***
Aerobic training 0.8 (0.4-1.2) (n=54) 0.4 (0.3-0.6)  (n=51)
0.4 (0.3-0.6)  
(n=49) 0.3 (0.2-0.5) (n=35) −0.1 (−0.2 to 
0.0)
−0.1 (−0.2 to 
0.0)
−0.1 (−0.2 to 
0.0)Relaxation 0.4 (0.3-0.7) (n=46) 0.4 (0.3-0.5)  (n=41)
0.4 (0.3-0.6)  
(n=41) 0.4 (0.3-0.5) (n=32)
Mean (SD) quality of life (EQ-5D-5L) index score†††
Aerobic training 0.5 (0.3) (n=104) 0.7 (0.3) (n=87) 0.7 (0.3)  (n=87)
0.7 (0.3)




0.0 (−0.08 to 
0.08)Relaxation 0.5 (0.3) (n=93) 0.7 (0.3) (n=82) 0.6 (0.3)  (n=77)
0.7 (0.3)
Mean (SD) depression (CES-D) sum score‡‡‡
Aerobic training 10 (7) (n=85) 9 (6) (n=72) 10 (7) (n=71) 8 (7) −1 (−3 to 1) 0 (−2 to 2) 0 (−2 to 1)Relaxation 10 (5) (n=72) 10 (5) (n=67) 10 (6) (n=64) 9 (5)
Table 3 | Results for secondary outcome measures by aerobic physical fitness training or relaxation sessions (control group)
(continued)
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relaxation group during the intervention period. 
In contrast, participants in the relaxation group 
reported dizziness more often than participants in 
the aerobic physical fitness training group (see table 
4). People with stroke are at increased risk for repeat 
falls, and fall prevention programmes are needed.36 
Hence, and in opposition to current guideline 
recommendations,7 treadmill based aerobic physical 
fitness training should be administered with caution 
early after moderate to severe stroke. A Very Early 
Rehabilitation Trial after stroke (AVERT) mobilised 
participants within 24 hours after stroke and found a 
worse outcome after three months, but no differences 
were observed in walking related outcome measures.37 
Although AVERT, LEAPS, and the present trial differ 
in terms of study population, timing after stroke, and 
type of intervention, these studies did not replicate 
the previously reported beneficial effects of specific 
rehabilitation interventions in small cohorts, while at 
the same time detecting a larger number of relevant 
adverse events and serious adverse events.
Strengths and limitations of this study
This is a randomised controlled, multicentre stroke 
rehabilitation trial assessing the efficacy and safety of 
an aerobic, bodyweight supported fitness intervention 
compared with relaxation in adults with subacute 
stroke. Compared with previous post-stroke fitness 
trials,6 our trial recruited a substantially larger sample 
size comprising adults with moderate to severe stroke 
and assessed a broad spectrum of patient centred 
outcome measures. The study does, however, have 
limitations. Firstly, recruitment took place between 
days 5 and 45 after stroke, therefore variations in early 
neurological recovery could have increased differences 
in outcome measures and might have affected current 
conclusions. However, the impact of the additionally 






ing (n=105), relaxation 
sessions (n=95)
Post-intervention: 
aerobic physical fitness 
training (n=87), relaxa-
tion sessions (n=85)
Follow-up Treatment effect (95%CI)*
3 months: aerobic 
physical fitness train-
ing (n=89), relaxation 
sessions (n=77)
6 months: aerobic 
physical fitness train-








Mean (SD) sleep (PSQI) sum score§§§
Aerobic training 4 (3) (n=96) 5 (4) (n=83) 6 (3) (n=84) 5 (4) (n=77) −1 (−2 to 0) −1 (−1 to 0) −1 (−1 to 0)Relaxation 5 (3) (n=88) 6 (4) (n=78) 6 (4) (n=74) 5 (3) (n=60)
Median (interquartile range) cognition (MOCA) sum score¶¶¶
Aerobic training 24 (21-27) (n=104) 26 (22-28)  (n=86)
25 (22-28)  
(n=89)
26 (24-29)
0 (−1 to 1) −1 (−1 to 1) 0 (−1 to 1)Relaxation 24 (17-26) (n=94) 25 (19-27)  (n=84)
25 (21-28)  
(n=75) 26 (21-28) (n=64)
Median (interquartile range) cognitive processing speed (TMT A) (sec)****
Aerobic training 70 (52-122) (n=104) 56 (42-120)  (n=85)
51 (37-84) 52 (33-69)
5 (−10 to 20) 7 (−7 to 22) 1 (−14 to 16)Relaxation 85 (60-197) (n=94) 64 (47-123)  (n=84)
67 (43-102) 60 (42-82)
Median (interquartile range) executive functioning (TMT B) (sec)††††
Aerobic training 222 (127-301) 
(n=104)
97 (93-301)  
(n=85)
139 (88-301) 125 (78-216)
−5 (−21 to 11) −1  (−17 to 16) −6 (−22 to 10)Relaxation 301 (157-301) (n=93) 218 (134-301)  (n=84)
166 (110-301) 150 (92-301)
Mean (SD) word fluency (RWT) sum score‡‡‡‡
Aerobic training 38 (19) (n=104) - 43 (19) (n=86) - - 1 (−2 to 3) -Relaxation 34 (18) (n=92) - 40 (18) (n=73) -
Analyses are based on mixed models analysis of covariance (adjusted for baseline value, age, sex, functional ambulation category, and centre heterogeneity). Estimates are based on three level 
mixed models and multiple imputation (n=600 measures, 200 participants, six study centres) positive values favour aerobic physical fitness training. Missing values were imputed by multiple 
imputation, except for modified Ranking scale score, use of walking aids, and functional ambulation category (imputation process was done separately for treatment groups). If the number of 
valid data points differs for specific variables, the number of available data points is listed in brackets. Data missing due to missing at random are imputed (see supplementary appendix).
*Secondary outcomes are exploratory and not meant for hypothesis testing. P values are therefore not reported.
†21 participants were unable to walk 10 m to assess maximal walking speed—values were therefore imputed using single value imputation by taking half of lowest value of total cohort.
‡17 participants were unable to walk for entire time of six minutes—for those participants distance walked up to stopping is used. 28 participants were in poor physical condition and could not 
do the test—values were therefore imputed, using single value imputation by taking half of lowest value of total cohort.
§Difference between groups at three months after stroke presented as odds ratios (95% confidence intervals, odds ratio >1 favours aerobic training intervention. Calculations not adjusted for 
centre heterogeneity. For walking aids odds ratio >1 means dependence on walking aids in aerobic training group. Table 2 shows results for primary efficacy outcomes.
¶15 baseline actigraphy values were missing due to logistic reasons. Data are assumed to be missing completely at random.
**Missing values in step length are due to implausible number of steps within 10 m gait assessment, or 10 m walk test not completed.
††Missing values in step cadence are due to implausible number of steps within 10 m gait assessment, or 10 m walk test not completed.
‡‡11 participants showed no initial motor impairment and are excluded from analysis.
§§One baseline value on medical research council scale is missing at random in aerobic group.
¶¶Functional ambulation category was initially assessed at baseline only and not at follow-up; therefore some follow-up values are missing.
***Spirometry data are missing mostly due to technical issues. Baseline values are available for 100 participants (n=54 aerobic training, n=46 relaxation).
†††Six baseline values for EuroQol quality of life questionnaire (EQ-5D-5L) index score were missing for various reasons (aphasia, fatigue, understanding difficulties).
‡‡‡19 baseline values for Center for Epidemiologic Studies depression scale (CES-D) sum score were missing owing to aphasia, fatigue, understanding difficulties, not able to respond to 
question. 24 data points had to be excluded because participants fulfilled criteria for unreliable data (lie, criteria ≤28).
§§§16 baseline values for Pittsburgh sleep quality index (PSQI) sum score were missing owing to aphasia, fatigue, and understanding difficulties.
¶¶¶Two baseline values for Montreal cognitive assessment (MOCA) sum score were missing owing to fatigue.
****Two baseline values for trail making test (TMT) part A were missing owing to poor vision and fatigue.
††††Three baseline values for trail making test (TMT) part B were missing owing poor vision, fatigue, and failure of time recording by assessor.
‡‡‡‡The Regensburger Wortflüssigkeitstest (RWT) was only assessed at baseline and at three months’ follow-up. Four baseline values for RWT were missing owing to severe aphasia.
Table 3 | Continued
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participants were recruited within the time window 
of early subacute stroke,10 and subgroup analyses 
(see fig 4) could not detect differences in treatment 
effects for participants receiving the intervention early 
after stroke (<2 weeks) compared with late after stroke 
(>2 weeks). Secondly, despite random allocation, 
the aerobic physical fitness training group was more 
severely affected at baseline, but we adjusted for 
baseline values in statistical analyses. Thirdly, findings 
are only applicable to moderately to severely affected 
adults with subacute stroke and are not generalisable 
to the stroke population, especially not to people with 
chronic stroke. Fourthly, less than 4% of the screened 
adults with stroke were included in the trial, and 
the severity of impairment might have resulted in a 
substantial proportion of participants terminating the 
intervention prematurely; a limitation often observed 
in early stroke rehabilitation trials.9 11 38 Fifthly, the 
intervention period of four weeks could have been 
too short to show additional benefits compared with a 
relaxation control intervention; and the lack of a control 
arm for usual care only limits the understanding of the 
treatment effects of relaxation therapy.
Clinical implications and future research
Our trial provides evidence that an aerobic physical 
fitness training intervention with bodyweight support 
cannot be generally endorsed in adults after subacute 
stroke and should be administered with caution when 
applied early after moderate or severe stroke. Carers 
should closely monitor people with stroke for recurrent 
cardiovascular events and provide additional support 
after training to prevent falls. Despite these findings, 
aerobic physical fitness could still be an invaluable 
part of stroke rehabilitation—for example, in people 
with chronic stroke or mildly affected with subacute 
stroke.
Based on our results, trials should investigate if 
longer intervention periods are necessary to capture 
major changes in activities of daily living, assess the 
treatment effects of relaxation programmes compared 
with usual care, and recruit participants at fixed time 
points after stroke to reduce variance in outcome 
measures.10 39 Future trials might also evaluate 
whether the observed sex specific difference in change 
of maximal walking speed or the effects on endurance 
measures can be replicated.
Table 4 | Safety outcomes by aerobic physical fitness training or relaxation session (control group)
Events
Aerobic physical fitness 
training (n=105)
Relaxation sessions 
(n=95) Total cohort (n=200)
Incidence rate ratio 
(95% CI)*
Serious adverse events† (from baseline to three months after stroke)
Median (interquartile range) 
follow-up (days) 68 (56-78) 69 (54-77) 66 (56-78)
Total No 22 9 31
Incidence rate/100 person 
months (95% CI) 13.19 (9.22 to 18.86) 7.28 (4.39 to 12.08) 10.38 (7.75 to 13.90) 1.81 (0.97 to 3.36)
Cardiovascular event 0 0 0 -
No with recurrent stroke 8 3 11 -
Incidence rate/100 person 
months (95% CI) 3.52 (1.76 to 7.03) 1.46 (0.47 to 4.52) 2.54 (1.41 to 4.58) 2.41 (0.64 to 9.10)
No of hospital admissions 14 5 19 -
Incidence rate/100 person 
months (95% CI) 6.15 (3.64 to 10.39) 2.43 (1.01 to 5.83) 4.39 (2.80 to 6.87) 2.53 (0.91 to 7.04)
No of deaths 0 1 1 -
Incidence rate/100 person 
months (95% CI) - 0.49 (0.07 to 3.45) 0.23 (0.03 to 1.64) 0.30 (0.01 to 7.42)‡
Self reported adverse events§ (during intervention period)
Median (interquartile range) 
follow-up time (days)
33 (29-36) 22 (28-36) 33 (29-36)
No of falls 36 14 50 -
Incidence rate/100 person 
months (95% CI)
32.40 (23.37 to 44.92) 13.84 (8.19 to 23.36) 11.8 (8.9 to 15.5) 2.34 (1.26 to 4.34)
No of fractures 0 0 0 -
No with pain 68 44 112 -
Incidence rate/100 person 
months (95% CI)
61.20 (48.25 to 77.62) 43.49 (32.36 to 58.44) 26.1 (21.7 to 31.4) 1.41 (0.96 to 2.06)
No with fatigue 29 21 50 -
Incidence rate/100 person 
months (95% CI)
26.10 (18.14 to 37.56) 20.76 (13.53 to 31.83) 23.55 (17.85 to 31.07) 1.26 (0.72 to 2.20)
No with dizziness 5 14 19 -
Incidence rate/100 person 
months (95% CI)
4.50 (1.87 to 10.81) 13.84 (8.19 to 23.36) 8.95 (5.71 to 14.03) 0.33 (0.12 to 0.90)
Other 8 4 12 -
Incidence rate/100 person 
months (95% CI)
7.20 (3.60 to 14.40) 3.95 (1.48 to 10.53) 5.65 (3.21 to 9.95) 1.82 (0.55 to 6.05)
*Calculated using Poisson regression.
†Serious adverse event can belong to more than one category (eg, recurrent stroke and hospital admission). Thus total number of participants with a 
serious adverse event does not equal sum of individual categories of serious adverse events.
‡Calculated using penalised maximum likelihood logistic regression (firthlogit command in stata).
§Adverse events can occur multiple times in a participant. Time interval ranges from baseline to follow-up at three months after stroke or until last 
observation, if participant dropped out.
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Conclusion and policy implications
A four week intervention of a bodyweight supported, 
treadmill based, aerobic physical fitness training in 
adults in the subacute phase of moderate to severe 
stroke is not superior to relaxation sessions with regard 
to maximal walking speed and activities of daily living. 
The risk of falls was higher in participants randomised 
to aerobic physical fitness training. Compared with 
current guideline recommendations,7 these results do 
not appear to support the use of aerobic bodyweight 
supported fitness training in this stroke population.
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